Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Mar 30, 2022 | (FY)Mar 30, 2021 | (FY)Mar 30, 2020 | (FY)Mar 30, 2019 | (FY)Mar 30, 2018 | (FY)Mar 30, 2017 | (Q4)Mar 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||||
| Cash income from operating activities | -14.46%11.77M | 449.65%13.76M | -27.33%2.5M | 94.38%3.45M | -80.60%1.77M | 28.99%9.13M | 109.53%7.08M | 38.59%3.38M | 2.44M | 91.22K |
| Revenue from customers | -14.05%11.83M | 449.65%13.76M | -27.33%2.5M | 94.38%3.45M | -80.60%1.77M | 28.99%9.13M | 109.53%7.08M | 38.59%3.38M | --2.44M | --91.22K |
| Other cash income from operating activities | ---55.4K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash paid | -1.08%-14.93M | -398.86%-14.77M | 49.11%-2.96M | -158.14%-5.82M | 78.86%-2.25M | -37.57%-10.66M | -37.50%-7.75M | -0.36%-5.64M | -5.62M | -542.84K |
| Payments to suppliers for goods and services | -1.08%-14.93M | -398.86%-14.77M | 49.11%-2.96M | -158.14%-5.82M | 78.86%-2.25M | -37.57%-10.66M | -37.50%-7.75M | -0.36%-5.64M | ---5.62M | ---542.84K |
| Direct interest paid | ---- | 52.81%-52.12K | 35.06%-110.45K | -194.08%-170.08K | 85.32%-57.83K | -20.61%-393.87K | -44.56%-326.56K | -501.19%-225.91K | ---37.58K | ---3.17K |
| Direct interest received | 24.47%8.85K | -53.66%7.11K | 95.06%15.35K | 439.34%7.87K | 26.87%1.46K | -45.26%1.15K | -92.98%2.1K | -67.46%29.93K | --91.96K | --49.96K |
| Direct tax refund paid | --67.74K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating cash flow | -191.66%-3.08M | -91.25%-1.06M | 78.20%-552.97K | -371.11%-2.54M | 71.99%-538.52K | -93.25%-1.92M | 59.46%-994.88K | 21.45%-2.45M | ---3.12M | ---404.84K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 67.25%-637.03K | -566.46%-1.95M | -272.99%-291.9K | -3,451.56%-78.26K | 109.77%2.34K | -65.11%-23.9K | -125.63%-14.47K | 116.82%56.46K | -335.62K | -105.88K |
| Capital expenditure reported | 73.75%-428.85K | -531.07%-1.63M | ---258.83K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net PPE purchase and sale | 70.32%-4.3K | 56.15%-14.5K | -188.65%-33.07K | -590.71%-11.46K | 109.77%2.34K | -65.11%-23.9K | 17.74%-14.47K | 94.76%-17.59K | ---335.62K | ---105.88K |
| Net intangibles purchas and sale | 31.47%-203.88K | ---297.51K | ---- | ---66.8K | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --74.05K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 67.25%-637.03K | -566.46%-1.95M | -272.99%-291.9K | -3,451.56%-78.26K | 109.77%2.34K | -65.11%-23.9K | -125.63%-14.47K | 116.82%56.46K | ---335.62K | ---105.88K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 116.18%4.98M | 2.3M | 46.98%4.25M | 42.92%2.89M | 76.36%2.02M | 8,678.44%1.15M | 46.91%-13.36K | -25.16K | -6.59K | |
| Net issuance payments of debt | ---- | ---- | ---- | 48.47%-4.63K | 44.81%-8.98K | -7.84%-16.28K | -12.98%-15.09K | -5.36%-13.36K | ---12.68K | ---137 |
| Net common stock issuance | 122.21%4.23M | --1.9M | ---- | 46.69%4.25M | 49.54%2.9M | 66.89%1.94M | --1.16M | ---- | ---- | ---- |
| Net other financing activities | 87.50%750K | --400K | ---- | ---- | ---- | ---- | ---- | ---- | ---12.49K | ---6.45K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 116.18%4.98M | --2.3M | ---- | 46.98%4.25M | 42.92%2.89M | 76.36%2.02M | 8,678.44%1.15M | 46.91%-13.36K | ---25.16K | ---6.59K |
| Net cash flow | ||||||||||
| Beginning cash position | -64.50%461.12K | -38.02%1.3M | -25.41%2.1M | 356.30%2.81M | 16.61%615.74K | -33.37%528.02K | -74.81%792.45K | -53.11%3.15M | --6.71M | --7.27M |
| Current changes in cash | 279.28%1.26M | 17.09%-700.51K | -151.83%-844.87K | -30.70%1.63M | 3,061.23%2.35M | -45.51%74.41K | 105.66%136.55K | 30.82%-2.41M | ---3.49M | ---517.31K |
| Effect of exchange rate changes | -2.31%-108.01K | -319.32%-105.57K | 121.08%48.13K | -44.23%-228.34K | -1,288.80%-158.31K | 107.37%13.32K | -413.08%-180.75K | 173.70%57.73K | ---78.33K | ---41.21K |
| End cash Position | 226.47%1.61M | -62.06%492.84K | -69.16%1.3M | 49.89%4.21M | 356.30%2.81M | -17.71%615.74K | -5.58%748.25K | -74.81%792.45K | --3.15M | --6.71M |
| Free cash from | -23.30%-3.72M | -257.25%-3.02M | 67.70%-844.87K | -385.64%-2.62M | 72.33%-538.52K | -92.84%-1.95M | 59.16%-1.01M | 28.56%-2.47M | ---3.46M | ---510.72K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |